Prostate-specific antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent (125)I seed brachytherapy for prostate cancer

بواسطة Kovalainen, Essi, Vaarala, Markku H.
الحاوية / القاعدة Mol Clin Oncol (2016)

External beam radiation for the treatment of castration-resistant prostate cancer following primary hormonal therapy with androgen ablation: Analysis and outcome of 21 patients

بواسطة Kuusk, Teele, Pulliainen, Kristiina, Vaarala, Markku H.
الحاوية / القاعدة Mol Clin Oncol (2017)

CIP2A expression is increased in prostate cancer

بواسطة Vaarala, Markku H, Väisänen, Marja-Riitta, Ristimäki, Ari
منشور في 2010

Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma

بواسطة Ronkainen, Hanna, Kauppila, Saila, Hirvikoski, Pasi, Vaarala, Markku H
منشور في 2010

Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2...

بواسطة Laru, Lauri, Ronkainen, Hanna, Ohtonen, Pasi, Vaarala, Markku H.
الحاوية / القاعدة World J Surg Oncol (2021)

Identification of androgen-regulated genes in human prostate

بواسطة VAARALA, MARKKU H., HIRVIKOSKI, PASI, KAUPPILA, SAILA, PAAVONEN, TIMO K.
منشور في 2012

Sacral nerve stimulation lead implantation using the o-arm

بواسطة Hellström, Pekka A, Katisko, Jani, Finnilä, Pertti, Vaarala, Markku H
منشور في 2013

Prostate cancer incidence in men with self-reported prostatitis after 15 years of follow-up

بواسطة Vaarala, Markku H., Mehik, Aare, Ohtonen, Pasi, Hellström, Pekka A.
الحاوية / القاعدة Oncol Lett (2016)

Evaluation of neuroendocrine markers in renal cell carcinoma

بواسطة Ronkainen, Hanna, Soini, Ylermi, Vaarala, Markku H, Kauppila, Saila, Hirvikoski, Pasi
منشور في 2010

Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer

بواسطة VÄISÄNEN, MARJA-RIITTA, JUKKOLA-VUORINEN, ARJA, VUOPALA, KATRI S., SELANDER, KATRI S., VAARALA, MARKKU H.
منشور في 2013

8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma

بواسطة Soini, Ylermi, Haapasaari, Kirsi-Maria, Vaarala, Markku H, Turpeenniemi-Hujanen, Taina, Kärjä, V, Karihtala, Peeter
منشور في 2011

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

بواسطة Ronkainen, Hanna, Hirvikoski, Pasi, Kauppila, Saila, Vuopala, Katri S, Paavonen, Timo K, Selander, Katri S, Vaarala, Markku H
منشور في 2011

Treatment of renal angiomyolipoma: pooled analysis of individual patient data

بواسطة Kuusk, Teele, Biancari, Fausto, Lane, Brian, Tobert, Conrad, Campbell, Steven, Rimon, Uri, D’Andrea, Vito, Mehik, Aare, Vaarala, Markku H.
الحاوية / القاعدة BMC Urol (2015)

Changing trends in symptomatology, diagnostics, stage and survival of prostate cancer in Northern Finland during a period of 20 years

بواسطة Kavasmaa, Outi T, Tyomkin, Dimitri B, Mehik, Aare, Parpala, Teija M, Tonttila, Panu, Paananen, Ilkka, Kunelius, Pekka, Vaarala, Markku H, Ohtonen, Pasi, Hellström, Pekka A
منشور في 2013

Tumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma

بواسطة Mella, Mikko, Kauppila, Joonas H, Karihtala, Peeter, Lehenkari, Petri, Jukkola-Vuorinen, Arja, Soini, Ylermi, Auvinen, Päivi, Vaarala, Markku H, Ronkainen, Hanna, Kauppila, Saila, Haapasaari, Kirsi-Maria, Vuopala, Katri S, Selander, Katri S
الحاوية / القاعدة Oncoimmunology (2015)